Home » Authors » Don Long

Articles by Don Long

Piper Jaffray Health Care Conference: Boston Sci tackles challenge of product growth, execution

Jan. 26, 2005

ViaCell Prices At Low End, But Gets $52.5M In 2005's First IPO

Jan. 24, 2005

ViaCell Prices At Low End, But Gets $52.5M In 2005's First IPO

Jan. 24, 2005

SurModics acquires remaining portion of InnoRx for $4.1M

Jan. 20, 2005

International Symposium on Endovascular Therapy: Belgian researchers present 'absorbable' metal stent data

Jan. 20, 2005

JAMA report seen supporting market uptake for Cypher DES

Jan. 13, 2005

New LSA 'angels' firm will offer device and biotech support

Jan. 7, 2005

Chlorhexidine gluconate key aid in battle vs. catheter infections

Jan. 4, 2005

Demographics drive health help in plastic surgery, cardio arenas

Jan. 4, 2005

Angioplasty/stenting, keyhole bypass are combined in a 'first'

Jan. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...